FS Bancorp (FSBW) CFO Equity Award and Small Share Sale on Aug 15, 2025
Rhea-AI Filing Summary
Phillip Dean Whittington, Chief Financial Officer and director of FS Bancorp, Inc. (FSBW), reported multiple Section 16 transactions dated 08/15/2025. He received an award of 2,000 restricted shares under the 2018 Equity Incentive Plan that vest 25% per year beginning August 15, 2026, increasing his direct holdings to 5,396 shares. He sold 317 shares at $40.14, reducing direct holdings to 5,079 shares. He was also granted 4,000 stock options with a $40.14 exercise price that vest 25% per year beginning August 15, 2026 and expire August 15, 2035, bringing total beneficially owned shares related to options to 9,600 (direct).
Positive
- Transparent disclosure of restricted stock award and option grant with stated vesting schedule
- Vesting tied to multi-year schedule (25% per year), which aligns management incentives with long-term performance
- Form 4 properly signed and shows both direct and indirect holdings, including ESOP disclosure
Negative
- Insider sale of 317 shares at $40.14 slightly reduces direct holdings (to 5,079), which may prompt investor questions about timing
- Limited context on total outstanding company shares or percentage ownership, so materiality relative to company size is unclear
Insights
TL;DR: Insider received equity compensation and sold a small number of shares; grants vest over four years.
The form shows a routine insider compensation event: an award of 2,000 restricted shares and a grant of 4,000 options at a $40.14 strike, both with standard four-year annual vesting starting August 15, 2026. The sale of 317 shares at $40.14 appears modest relative to the grant sizes and the holdings reported. These transactions are consistent with compensation and liquidity needs rather than a material change in ownership.
TL;DR: Disclosure aligns with Section 16 requirements; vesting schedule and option expiry are clearly stated.
The Form 4 is properly signed and discloses direct and indirect holdings, an ESOP interest, and explicit vesting terms for both restricted stock and options. The presence of a sale, grants, and the ESOP interest are material to governance transparency but do not indicate any governance anomaly. Timing and quantities are documented for investor review.
FAQ
What transactions did Phillip Whittington report for FSBW on 08/15/2025?
What are the vesting terms for the restricted shares and options?
What is the exercise price and expiration for the stock options reported?
How many shares does Whittington beneficially own after these transactions?
Was the Form 4 properly executed and filed?